K N Manolopoulos1, F Karpe, K N Frayn. 1. Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK. k.manolopoulos@bham.ac.uk
Abstract
AIMS/HYPOTHESIS: Fatty acid entrapment in femoral adipose tissue has been proposed to prevent ectopic fat deposition and visceral fat accumulation, resulting in protection from insulin resistance. Our objective was to test the hypothesis of femoral, compared with abdominal, adipose tissue resistance to adrenergic stimulation in vivo as a possible mechanism. METHODS: Regional fatty acid trafficking, along with the measurement of adipose tissue blood flow (ATBF) with (133)Xe washout, was studied with the arteriovenous difference technique and stable isotope tracers in healthy volunteers. Adrenergic agonists (isoprenaline, adrenaline [epinephrine]) were infused either locally by microinfusion or systemically. Local microinfusion of adrenoceptor antagonists (propranolol, phentolamine) was used to characterise specific adrenoceptor subtype effects in vivo. RESULTS: Femoral adipose tissue NEFA release and ATBF were lower during adrenaline stimulation than in abdominal tissue (p < 0.001). Mechanistically, femoral adipose tissue displayed a dominant α-adrenergic response during adrenaline stimulation. The α-adrenoceptor blocker, phentolamine, resulted in the 'disinhibition' of the femoral ATBF response to adrenaline (p < 0.001). CONCLUSIONS/ INTERPRETATION: Fatty acids, once stored in femoral adipose tissue, are not readily released upon adrenergic stimulation. Femoral adipose tissue resistance to adrenaline may contribute to the prevention of ectopic fatty acid deposition.
AIMS/HYPOTHESIS: Fatty acid entrapment in femoral adipose tissue has been proposed to prevent ectopic fat deposition and visceral fat accumulation, resulting in protection from insulin resistance. Our objective was to test the hypothesis of femoral, compared with abdominal, adipose tissue resistance to adrenergic stimulation in vivo as a possible mechanism. METHODS: Regional fatty acid trafficking, along with the measurement of adipose tissue blood flow (ATBF) with (133)Xe washout, was studied with the arteriovenous difference technique and stable isotope tracers in healthy volunteers. Adrenergic agonists (isoprenaline, adrenaline [epinephrine]) were infused either locally by microinfusion or systemically. Local microinfusion of adrenoceptor antagonists (propranolol, phentolamine) was used to characterise specific adrenoceptor subtype effects in vivo. RESULTS: Femoral adipose tissue NEFA release and ATBF were lower during adrenaline stimulation than in abdominal tissue (p < 0.001). Mechanistically, femoral adipose tissue displayed a dominant α-adrenergic response during adrenaline stimulation. The α-adrenoceptor blocker, phentolamine, resulted in the 'disinhibition' of the femoral ATBF response to adrenaline (p < 0.001). CONCLUSIONS/ INTERPRETATION:Fatty acids, once stored in femoral adipose tissue, are not readily released upon adrenergic stimulation. Femoral adipose tissue resistance to adrenaline may contribute to the prevention of ectopic fatty acid deposition.
Authors: Siobhán E McQuaid; Konstantinos N Manolopoulos; A Louise Dennis; Jane Cheeseman; Fredrik Karpe; Keith N Frayn Journal: Obesity (Silver Spring) Date: 2010-01-07 Impact factor: 5.002
Authors: Fredrik Karpe; Barbara A Fielding; Vera Ilic; Ian A Macdonald; Lucinda K M Summers; Keith N Frayn Journal: Diabetes Date: 2002-08 Impact factor: 9.461
Authors: Siobhán E McQuaid; Leanne Hodson; Matthew J Neville; A Louise Dennis; Jane Cheeseman; Sandy M Humphreys; Toralph Ruge; Marjorie Gilbert; Barbara A Fielding; Keith N Frayn; Fredrik Karpe Journal: Diabetes Date: 2010-10-13 Impact factor: 9.461
Authors: Kim-Anne Lê; Emily E Ventura; Jessica Q Fisher; Jaimie N Davis; Marc J Weigensberg; Mark Punyanitya; Houchun H Hu; Krishna S Nayak; Michael I Goran Journal: Diabetes Care Date: 2011-02 Impact factor: 19.112
Authors: Samantha L Hocking; Rebecca L Stewart; Amanda E Brandon; Eurwin Suryana; Ella Stuart; Emily M Baldwin; Ganesh A Kolumam; Zora Modrusan; Jagath R Junutula; Jenny E Gunton; Michael Medynskyj; Sinead P Blaber; Elisabeth Karsten; Benjamin R Herbert; David E James; Gregory J Cooney; Michael M Swarbrick Journal: Diabetologia Date: 2015-04-22 Impact factor: 10.122
Authors: Konstantinos N Manolopoulos; Michael W O'Reilly; Iwona J Bujalska; Jeremy W Tomlinson; Wiebke Arlt Journal: J Clin Endocrinol Metab Date: 2017-04-01 Impact factor: 5.958
Authors: Hannah Scotney; Michael E Symonds; James Law; Helen Budge; Don Sharkey; Konstantinos N Manolopoulos Journal: Metabolism Date: 2017-01-19 Impact factor: 8.694